T Konno

560 total citations
17 papers, 427 citations indexed

About

T Konno is a scholar working on Cancer Research, Hepatology and Molecular Biology. According to data from OpenAlex, T Konno has authored 17 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 8 papers in Hepatology and 4 papers in Molecular Biology. Recurrent topics in T Konno's work include Cancer, Hypoxia, and Metabolism (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Cancer, Lipids, and Metabolism (6 papers). T Konno is often cited by papers focused on Cancer, Hypoxia, and Metabolism (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Cancer, Lipids, and Metabolism (6 papers). T Konno collaborates with scholars based in Japan and United Kingdom. T Konno's co-authors include Hajime Maeda, S Iwamoto, Y Yumoto, K Ohnishi, K Okuda, Kenji Jinno, Yoshihiro Araki, Yuya Miyauchi, Y Matsumura and K. Yamasaki and has published in prestigious journals such as Radiology, European Journal of Cancer and Experimental Biology and Medicine.

In The Last Decade

T Konno

17 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T Konno Japan 8 275 105 83 69 65 17 427
Y Yumoto Japan 7 272 1.0× 125 1.2× 40 0.5× 50 0.7× 50 0.8× 14 383
Alessandra R. Garcia United States 4 356 1.3× 95 0.9× 52 0.6× 46 0.7× 97 1.5× 4 458
Qungang Shan China 13 153 0.6× 106 1.0× 57 0.7× 83 1.2× 70 1.1× 24 432
Jianmin Ding China 11 298 1.1× 199 1.9× 42 0.5× 55 0.8× 55 0.8× 36 464
Gaurav Kumar Israel 11 196 0.7× 58 0.6× 74 0.9× 112 1.6× 68 1.0× 14 447
Jiayan Ni China 12 383 1.4× 190 1.8× 74 0.9× 62 0.9× 104 1.6× 26 537
Xi Ai China 10 101 0.4× 64 0.6× 80 1.0× 163 2.4× 40 0.6× 24 361
Seiji Hosaka Japan 7 161 0.6× 115 1.1× 75 0.9× 266 3.9× 39 0.6× 20 538
Valérie Ardisson France 11 153 0.6× 30 0.3× 38 0.5× 54 0.8× 91 1.4× 19 314
Gianmarco Villano Italy 13 99 0.4× 114 1.1× 115 1.4× 187 2.7× 39 0.6× 28 426

Countries citing papers authored by T Konno

Since Specialization
Citations

This map shows the geographic impact of T Konno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Konno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Konno more than expected).

Fields of papers citing papers by T Konno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T Konno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Konno. The network helps show where T Konno may publish in the future.

Co-authorship network of co-authors of T Konno

This figure shows the co-authorship network connecting the top 25 collaborators of T Konno. A scholar is included among the top collaborators of T Konno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T Konno. T Konno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Takahashi, Masahide, Kazuhiko Okada, T Konno, et al.. (2021). Fibronectin plays a major role in hypoxia-induced lenvatinib resistance in hepatocellular carcinoma PLC/PRF/5 cells.. PubMed. 76(12). 594–601. 8 indexed citations
2.
Seymour, Leonard W., Simon Olliff, Christopher Poole, et al.. (1998). A novel dosage approach for evaluation of SMANCS [poly-(styrene-co-maleyl-half-n-butylate) - neocarzinostatin] in the treatment of primary hepatocellular carcinoma.. International Journal of Oncology. 12(6). 1217–23. 25 indexed citations
3.
Nagamitsu, Akinori, et al.. (1998). Targeted cancer chemotherapy for VX2 tumour implanted in the colon with lipiodol as a carrier. European Journal of Cancer. 34(11). 1764–1769. 16 indexed citations
4.
Oda, Takeshi, et al.. (1998). Targeted vinblastine chemotherapy with two preparations of lipiodol contrast medium.. PubMed. 17(5A). 3521–9. 2 indexed citations
5.
Konno, T, et al.. (1998). [Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol].. PubMed. 25 Suppl 1. 10–8. 2 indexed citations
6.
Konno, T. (1992). Targeting chemotherapy for hepatoma: Arterial administration of anticancer drugs dissolved in lipiodol. European Journal of Cancer. 28(2-3). 403–409. 60 indexed citations
7.
T, Oda, et al.. (1991). [Antitumor activities of oily suspended zinostatin stimalamer (YM 881) against VX2 carcinoma implanted in the liver of rabbits--comparison with another anticancer agent].. PubMed. 18(14). 2423–8. 1 indexed citations
8.
Kimura, M, Yasuhiro Matsumura, T Konno, Yasuyuki Miyauchi, & Hiroshi Maeda. (1990). Enzymatic Removal of Bilirubin Toxicity by Bilirubin Oxidase In Vitro and Excretion of Degradation Products In Vivo. Experimental Biology and Medicine. 195(1). 64–69. 13 indexed citations
9.
Kubo, Michiaki, Tai Fuchigami, Soichiro Murata, T Konno, & Hiromichi Maeda. (1989). [A case of massive hepatoma which responded to SMANCS/Lipiodol regimen with intra-arterial infusion].. PubMed. 16(8 Pt 2). 2953–6. 1 indexed citations
10.
Kimura, Masamichi, et al.. (1989). [Antitumor activities of oily suspended YM881 (SMANCS) against VX2 carcinoma].. PubMed. 16(6). 2183–8. 1 indexed citations
11.
Jinno, Kenji, Y Yumoto, Toshihiro Wada, et al.. (1988). [Significance of lipiodol-CT in the evaluation of therapeutic effects of Lp-TAE for hepatocellular carcinoma--clinicopathologic study].. PubMed. 23(8). 1660–71. 2 indexed citations
12.
Konno, T & Hiroshi Maeda. (1988). [Targeting cancer chemotherapy using lipiodol as a carrier of anticancer drugs for hepatocellular carcinoma].. PubMed. 15(4 Pt 2-1). 1043–50. 1 indexed citations
13.
Konno, T. (1987). [Targeting chemotherapy of hepatocellular carcinoma by arterial administration of anticancer agents dissolved in lipiodol].. PubMed. 14(2). 373–80. 2 indexed citations
14.
Maeda, Hajime, et al.. (1987). Tumor targeting by arterial administration of lipids: rabbit model with VX2 carcinoma in the liver.. PubMed. 7(3 Pt B). 321–7. 35 indexed citations
15.
Maki, Shôjirô, et al.. (1986). [CT image of the liver cancer after administration of SMANCS/lipiodol].. PubMed. 13(4 Pt 2). 1603–10. 1 indexed citations
16.
Yumoto, Y, Kenji Jinno, Yoshihiro Araki, et al.. (1985). Hepatocellular carcinoma detected by iodized oil.. Radiology. 154(1). 19–24. 249 indexed citations
17.
Konno, T, et al.. (1984). A clinical trial of live attenuated varicella vaccine (Biken) in children with malignant diseases.. PubMed. 27(2-3). 73–5. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026